Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

From the first article you linked: The study fi

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154899
(Total Views: 671)
Posted On: 05/03/2020 12:53:54 AM
Posted By: nmbr1stckpckr
Re: Sunny3999 #31610
From the first article you linked:

The study findings has serious implications as it means that the coronavirus is indeed evolving smartly and it is even far more potent and dangerous to the human body and we might start seeing newer and deadly clinical manifestations which is already being witnessed and also it could indicate that in communities with asymptomatic patients and also in recovered patients, the coronavirus is still evolving and becoming more lethal and its only when it would manifest chronic symptoms.

Also, it is most likely that here will be no successful vaccine ever developed that can stop the SARS-CoV-2 coronavirus. Despite all the publicity and lies, it is impossible for a vaccine to be developed for a virus that has more complicated and far more potent attributes than the HIV virus, which for the last 30 year have yet to have a successful vaccine developed.

Medical researchers and governments should stop selling dreams to the public and instead focus on developing drugs that can suppress viral loads, suppress cytokine storms and also treat the various emerging clinical manifestations including not just pneumonia and ARD but also clotting issues, the damages of the epithelial linings of blood vessels and the gastrointestinal tract, the damages of renal cells, immune T-cells and even certain types of cardiac cells etc. There is not going to be a single drug that can cure or treat COVID-19 as it evolves to become more complicated.


LERONLIMAB!

SARS-COV-2 is depressing and frightful! I don't dare go anyware without a mask and I am hyper aware of how people around me are treating the seriousness of the infection.


(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us